Verastem
Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. In January 2012, Verastem went public (NASDAQ: VSTM).
Based based in United States, Verastem works in healthcare, founded in 2010.
Within the healthcare space, the company focuses on its core offering rather than a broad product line.
Its base of operations is United States.
Directory data places it at the NASDAQ: VSTM | Bessemer portfolio company stage.
| Sector | Healthcare |
|---|---|
| Country | United States |
| Founded | 2010 |
| Stage | NASDAQ: VSTM | Bessemer portfolio company |
Website: www.verastem.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account